Anders Martin-Löf

Anders Martin-Löf is currently a Board Member at Cantargia. Prior to this, they served as an Advisor to the incoming CFO during their notice period at Oncopeptides AB from November 2018 to April 2022. Anders has also held the position of CFO at Cantargia AB and RaySearch Laboratories from August 2007 to April 2015 and November 2015 to August 2018, respectively. In addition, they served as Director of Investor Relations at Swedish Orphan Biovitrum AB (Sobi) from January 2003 to July 2007.

Anders Martin-Löf has a Master of Science in Engineering Physics from KTH Royal Institute of Technology, as well as a Bachelor of Science in Business administration and economics from Stockholm University. Anders also attended the National School of Computer Science and Applied Mathematics of Grenoble.